The FDA has granted an investigational device exemption to St. Jude Medical to allow it to start a clinical trial of its Duo catheter ablation system in the treatment of paroxysmal atrial fibrillation. The three-year study will test the safety and effectiveness of the device in 324 patients and will compare the system with an existing FDA-approved device.

Related Summaries